| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $24.6M | +8.8% | +62.7% |
| Cost of Revenue | $11.6M | +4.5% | +36.3% |
| Gross Profit | $12.9M | +13.0% | +97.1% |
| R&D Expense | $5.0M | +1.9% | +48.3% |
| SG&A Expense | $42.7M | +11.5% | +79.4% |
| Operating Income | -$34.8M | -9.5% | -68.8% |
| Pre-tax Income | -$34.1M | -4.2% | -57.0% |
| Income Tax | $35K | +2.9% | +94.4% |
| Net Income | -$34.2M | -4.2% | -58.8% |
| EPS (Basic) | -$0.61 | +4.7% | +51.2% |
| EPS (Diluted) | -$0.61 | +4.7% | +51.2% |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $291.3M | +66.1% | +436.0% |
| Accounts Receivable | $12.7M | +22.0% | — |
| Current Assets | $314.1M | +60.7% | — |
| Total Assets | $379.3M | +53.8% | — |
| Current Liabilities | $42.9M | +20.1% | — |
| Long-term Debt | $42.3M | +0.9% |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$63.0M | — | — |
| Capital Expenditures | $25.2M | — | — |
| Investing Cash Flow | -$30.6M | — | — |
| Financing Cash Flow | $147.3M | — | — |
| Free Cash Flow | -$88.2M | — | — |
| — |
| Total Liabilities | $91.4M | +10.6% | — |
| Stockholders' Equity | $288.0M | +75.5% | +211.7% |